Zapex

Quick links to important sections

Zapex

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zapex

What is Zapex? Identity, Class, and Purpose

Property Description
Active Ingredient Mirtazapine
Form Oral tablet (including ODT)
Pharmacological Class Noradrenergic and Specific Serotonergic Antidepressant (NaSSA)
Common Use Restoring mood balance
Origin Synthetic compound

What is Zapex? Identity and Active Ingredient

Zapex is a specific brand of a prescription-only psychotropic medicine with the single active ingredient Mirtazapine, which is a synthetic compound administered via the oral route. The drug is prepared as a single-ingredient product and is available as a standard oral tablet and a specialized orally disintegrating tablet (ODT). The availability of the ODT form is a differentiating feature, designed for rapid dissolution in the mouth without the need for water. The chemical entity Mirtazapine is classified as a tetracyclic compound, a complex structure that supports its pharmacological profile. The solid preparation is composed of the active substance combined with the necessary pharmaceutical excipients that facilitate its manufacture and reliable oral administration.

The Pharmacological Classification of Zapex

Zapex is classified pharmacologically as an Antidepressant, belonging to the sub-class known as the Noradrenergic and Specific Serotonergic Antidepressants (NaSSA). This classification distinguishes it structurally and functionally from other common antidepressant agents, such as the Selective Serotonin Reuptake Inhibitors (SSRIs). The NaSSA mechanism involves Mirtazapine acting as an antagonist at alpha2-autoreceptors, which increases the release and availability of the key neurotransmitters norepinephrine and serotonin in the brain. This dual action on neurotransmitter systems is the core reason for its NaSSA classification and is directly connected to its general therapeutic purpose: helping to regulate emotional stability and restore mood balance in patients with depressive states.

What side effects are possible with Zapex?

Possible Side Effects and Safety Information

The safety profile of Zapex (Mirtazapine) is officially defined by adverse reactions classified according to frequency and the body system affected, as documented in regulatory prescribing information.

Frequency-Classified Adverse Reactions

The most commonly reported effects fall into the Very Common (ge 10% incidence) and Common (1-10% incidence) categories. These expected adverse reactions primarily involve the central nervous system and metabolic systems:

Classification Examples of Officially Listed Effects
Very Common (ge 10%) Somnolence (drowsiness), Increased Appetite, Weight Gain, Dry Mouth
Common (1-10%) Dizziness, Asthenia (weakness), Confusion, Peripheral Edema, Constipation

Serious Adverse Reactions and Safety Constraints

Official labeling mandates specific warnings for serious adverse reactions. These include a noted risk for the emergence or worsening of Suicidal Thoughts and Behaviors, particularly in young adults during the start of treatment or dose adjustments. The label also documents the rare but severe risk of Agranulocytosis (a severe drop in white blood cells) and Serotonin Syndrome when used with certain other medications.

Safety constraints include that the medicine is contraindicated in individuals with a known hypersensitivity to Mirtazapine or those currently taking Monoamine Oxidase Inhibitors (MAOIs). Additionally, the label specifies that due to effects like somnolence, activities requiring mental alertness may be impaired.

Population-Specific Notes

The regulatory profile includes specific considerations for certain patient groups. Safety and efficacy have not been established in pediatric patients. Caution is required when prescribing to older adults, who may be at a higher risk for certain effects, such as hyponatremia (low sodium) and confusion. Dose adjustments may be necessary for patients with documented renal or hepatic impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Zapex (Mirtazapine) overdose primarily describes manifestations of central nervous system (CNS) depression. Documented clinical signs typically include somnolence, confusion, and memory impairment, which may be accompanied by mild hypertension, tremor, and tachycardia (fast heart rate).

A critical element of the official profile is the documented potential for Serotonin Toxicity, a potentially life-threatening complication that can escalate to Serotonin Syndrome. In such severe scenarios, regulatory instructions mandate that patients and caregivers seek medical advice immediately or call a doctor right away upon suspicion of overdose or the onset of severe symptoms.

The management of Mirtazapine overdose is strictly symptomatic and supportive because no specific antidote is available. This clinical procedure, as defined in regulatory documents, requires continuous hospital monitoring of vital signs and cardiac rhythm. Supportive treatment includes ensuring adequate airway, oxygenation, and ventilation. The profile also notes a relevant clinical consideration: drug clearance may be decreased in patients with documented hepatic or renal insufficiency, which informs the monitoring strategy.

Therapeutic Uses of Zapex

What Zapex Treats: Main Uses and Benefits

Zapex (Mirtazapine) is an antidepressant generally utilized for the acute treatment of Major Depressive Disorder (MDD) and may be part of symptomatic management in the relapse prevention phases. The medication is commonly used to help with multiple symptoms associated with depressive illness. Its use extends beyond the stabilization of mood by providing supportive relief for specific, distressing physical symptoms often co-occurring with depression.


Stabilization of Core Mood and Affective Symptoms

This medication may assist with supporting emotional stability by addressing the defining characteristics of a depressive episode, such as a persistently low or sad mood and a pervasive loss of interest or pleasure (anhedonia). The core therapeutic benefit contributes to easing the overall symptom load of these chronic feelings and supports patients during episodes of heightened discomfort.


Targeted Relief for Sleep and Appetite Disturbances

Zapex is considered relevant in clinical scenarios where depression is compounded by prominent insomnia (difficulty falling or staying asleep) and significant decreased appetite. This dual symptomatic support supports general well-being during symptomatic phases and assists with maintaining functional stability.

Quick Fact: Relief for Sleep and Appetite Disturbances Zapex is commonly applied when symptoms create noticeable physiological strain, specifically symptoms related to sleep disturbance and appetite changes, providing supportive symptomatic assistance in these domains.

Regulatory References

  1. Mirtazapine overview from NIH StatPearls

Eligibility and Restrictions for Use

Official Population Eligibility for Zapex (Mirtazapine)

Official regulatory documents define strict rules governing who can and cannot use Zapex, the brand name for the active ingredient Mirtazapine. The medicine is primarily approved for use in adults for the treatment of Major Depressive Disorder.


Eligibility Group Regulatory Status Constraint Details
Absolute Contraindication MUST NOT USE Patients with known hypersensitivity to mirtazapine or those currently taking or having recently stopped (within 14 days) a Monoamine Oxidase Inhibitor (MAOI).
Pediatric Population NOT APPROVED Use is not approved for children and adolescents under 18 years of age.
Organ Function CAUTION INDICATED Caution is required for patients with hepatic impairment or moderate to severe renal impairment (Clcr < 40 mL/min), as drug clearance is reduced.
Pregnancy/Lactation CONDITIONAL USE Use during pregnancy is advised only if clearly needed. Caution is required when used by nursing mothers, as the drug is excreted into human milk.

Eligibility is defined by regulatory bodies through these classifications. The strict contraindications create an absolute prohibition for specific concurrent medication use and allergies. For other populations, such as the elderly, pregnant patients, or those with impaired organ function, use is restricted and requires careful consideration, reflecting the established safety profile and differences in the body's ability to clear the medicine.

What should I know about interactions with other medicines?

Zapex Interactions with other medicines and products

Zapex (olanzapine) can interact with a wide range of other medicines and substances. It is essential to inform your doctor or pharmacist about all prescription drugs, over-the-counter medications, vitamins, supplements, and herbal products you are currently taking or plan to start.

Medications Affecting Olanzapine Levels

Certain medicines can change how Zapex is processed by the body, potentially increasing or decreasing its concentration and effects:

  • Enzyme Inhibitors: Medicines like fluvoxamine (for OCD) or ciprofloxacin (an antibiotic) can slow down the breakdown of Zapex, leading to an increased risk of side effects such as drowsiness and dizziness. A lower Zapex dose may be required.
  • Enzyme Inducers: Drugs such as carbamazepine (for seizures) or rifampicin (an antibiotic) can speed up the breakdown of Zapex, potentially reducing its effectiveness. A higher Zapex dose may be necessary.

Additive Effects

Combining Zapex with other medications that have similar effects can increase the risk of specific side effects:

Type of Medicine Potential Increased Risk
Central Nervous System (CNS) Depressants (e.g., benzodiazepines, opioids, alcohol) Increased sedation and drowsiness.
Blood Pressure Lowering Agents (e.g., ACE inhibitors, alpha-blockers) Increased risk of orthostatic hypotension (dizziness upon standing).
Serotonergic Drugs (e.g., certain antidepressants like SSRIs/SNRIs) Risk of serotonin syndrome (rare but serious condition).
QTc-Prolonging Drugs (e.g., certain antiarrhythmics, antibiotics) Increased risk of cardiac conduction abnormalities (heart rhythm issues).

Smoking and Other Interactions

  • Smoking (tobacco) can decrease the concentration of Zapex in the blood, potentially making it less effective. Patients who start or stop smoking may require a dose adjustment.
  • Alcohol consumption should be avoided due to the increased risk of severe drowsiness and sedation.

Mechanism of Action

How Zapex Works

The mechanism of Mirtazapine (Zapex) is defined by its strategic, multi-receptor antagonism, placing it in the Noradrenergic and Specific Serotonergic Antidepressant (NaSSA) class. Its action focuses exclusively on biological targets and pathways to achieve defined physiological effects.


Neurotransmitter Release Disinhibition

This domain covers the primary molecular interaction where the drug acts as an antagonist at presynaptic alpha2-adrenergic autoreceptors, functionally removing the inhibitory constraint on the release of norepinephrine and serotonin into the synapse. This disinhibitory action results in the simultaneous, functional increase in the availability of these key signaling molecules.

Selective Serotonin Pathway Channeling

This mechanism utilizes the enhanced serotonin supply by blocking the postsynaptic 5-HT2 and 5-HT3 receptors. This selective antagonism alters the serotonergic signal, functionally channeling the flow of serotonin toward the mathbf5-HT1 receptors, which results in a distinct and specific physiological response.

Central Arousal Modulation

The drug exhibits a high-affinity action through Histamine H1 receptor antagonism in the central nervous system. This molecular interaction profoundly modulates central arousal and vigilance signaling, defining a significant component of the drug's physiological effect profile. This mechanism is also subject to dose-dependent mechanistic constraints, where competing noradrenergic activity may lessen the H1-mediated dampening of central arousal at higher concentrations.

Dosage and Administration Information

Zapex (Mirtazapine) is administered exclusively via the oral route, available as a standard tablet and an Orally Disintegrating Tablet (ODT), in multiple strengths up to 45 mg. The dosage is typically taken once daily.

The standardized dosing protocol for adults begins with an initial dose of 15 mg once a day. Doses are generally administered in the evening, preferably near bedtime, or may be given in two divided doses with the larger portion at night. The total daily dose can be adjusted up to a recommended maximum of 45 mg, but dose changes must be made at intervals of no less than one to two weeks. The tablets may be taken either with or without food.

For the ODT formulation, the tablet is placed on the tongue where it dissolves rapidly and is swallowed with saliva, meaning no additional water is required for intake.

Specific adjustments to the standard regimen are outlined for certain populations. For patients with moderate to severe renal or hepatic impairment, a dose reduction may be necessary due to reduced drug clearance. While the starting dose for older adults is the same, any dose increase requires close supervision. Treatment is typically maintained for at least six months following symptom stability and must be concluded by gradual tapering.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Zapex


Evidence for the Acute Treatment of Major Depressive Disorder (MDD)

The primary evidence regarding the use of Zapex was developed through short-term Randomized Controlled Trials (RCTs) in adults diagnosed with Major Depressive Disorder. These studies compared Zapex against a placebo and other active antidepressant medications, monitoring outcomes related to symptom intensity using standardized scales like the Hamilton and Montgomery-Åsberg depression scales. The trials typically lasted six to eight weeks. While data show patterns related to how symptoms evolved over these initial weeks, the results apply only to the specific adult populations studied, and long-term outcomes are not well characterized.


Evidence on Specific Symptoms: Sleep and Appetite

Research specifically examined how Zapex was evaluated alongside co-occurring symptoms often associated with MDD, including sleep disturbance and decreased appetite. Studies monitored specific items on depression rating scales, reporting findings related to an increase in appetite and weight measurements in the observed populations, alongside descriptions of changes measured for sleep-related items.


Long-Term Evidence and Relapse Prevention Studies

Research explored the use of Zapex beyond the initial acute phase through placebo-controlled discontinuation trials. These studies focused on observing the risk of relapse in adults who had achieved symptom stabilization, with follow-up durations ranging up to approximately one year. Studies observed patterns where measurements of relapse rate differed between the groups continuing Zapex versus those switching to placebo. Follow-up durations are limited compared to acute trials, and long-term effects are not fully established.


Evidence in Specific Patient Groups

Research has been conducted in specific patient groups, most notably in older adults (geriatric patients), where research examined how symptom measurements evolved in this age group. Data for certain groups, such as children or adolescents, remain insufficient, and the available pivotal research did not focus on these populations. The results apply only to the populations studied.


Consistency of Evidence and Research Gaps

Overall, the studies contribute to the broader evidence landscape for Zapex, especially regarding its patterns of effect in acute MDD and studies observing outcomes related to sleep and appetite. However, a lack of long-term data remains a key gap, as Zapex's primary research relied on short follow-up durations. Comparative evidence against some newer antidepressants is lacking, and research is ongoing to provide a more complete understanding of Zapex in different research scenarios and populations.

Frequently Asked Questions (FAQ)

Common questions about Zapex (FAQ)

Q: What are the most frequent side effects listed in official documents for Zapex?

According to official documentation, the most frequently reported side effects (Very Common, meaning they occur in 10% or more of patients) are somnolence (drowsiness), increased appetite, weight gain, and dry mouth. These expected effects are listed in the regulatory safety profile of the medicine.

Q: Can Zapex affect my sleep patterns?

Official regulatory labeling lists somnolence, or feeling drowsy, as a Very Common side effect of Zapex. Due to this effect, official instructions state that the dosage is typically taken once daily, often in the evening or near bedtime.

Q: Can Zapex cause changes in weight?

Studies and official information indicate that both increased appetite and weight gain are listed as Very Common side effects of Zapex. This potential effect is noted in the established safety profile.

Q: Is Zapex safe to use if I have kidney issues?

The official product information notes that clearance is reduced in patients with moderate to severe renal impairment (kidney issues). Caution is indicated for this population, as the body’s ability to eliminate the medicine is decreased.

Q: Can Zapex be used during pregnancy?

Regulatory documents state that use of Zapex during pregnancy is advised only if the expected benefit is clearly needed. This is because there is insufficient data on its use in pregnant humans, and this decision requires a careful assessment based on the patient's individual needs.

Q: Is Zapex recommended for breastfeeding mothers?

Official information advises caution when Zapex is administered to a nursing woman because the drug is known to be excreted into human milk. This information is noted in the official prescribing documentation regarding use in nursing women.

Q: What happens if Zapex is stopped suddenly?

Regulatory guidance specifies that treatment with Zapex should be stopped by gradual dose reduction, also known as tapering. Sudden discontinuation is not recommended because it may be associated with various withdrawal-like reactions, and tapering is the recommended practice to help manage them.

Q: Is Zapex the same as other medicines used for the same conditions?

Zapex, with the active ingredient Mirtazapine, is classified as a Noradrenergic and Specific Serotonergic Antidepressant (NaSSA). This pharmacological classification distinguishes it functionally from other common classes of medicines used for similar conditions, such as the Selective Serotonin Reuptake Inhibitors (SSRIs).

Q: How long does it usually take to notice an effect from Zapex?

General information drawn from clinical experience suggests that some initial effects of Zapex may begin within about 1 to 2 weeks of starting treatment. However, the full therapeutic benefit may take longer to develop, which is a timeline that may be expected for a medicine of this type.

Q: Are there any common foods or supplements that interact with Zapex?

The product label does not mention restrictions on specific foods. However, the official documentation advises caution when Zapex is co-administered with herbal agents like St. John’s Wort, as this combination may increase the risk of specific side effects like serotonin syndrome.

Q: Can Zapex affect the results of lab tests?

Official safety information discusses the rare risk of a condition called Agranulocytosis, which involves a severe drop in white blood cells. This effect, as well as potential elevated liver enzymes, would be detected and monitored through standard lab tests.

Q: Does Zapex cause dependence if used for a long time?

The label does not use the term 'dependence,' but it strictly mandates a gradual tapering of the dose when discontinuing the medicine. This gradual reduction is a required practice to minimize potential withdrawal-like reactions after long-term use.

Q: Why is Zapex sometimes described as an 'atypical' medicine?

Zapex is often referred to as 'atypical' or 'novel' because its mechanism of action is unique compared to older classes of antidepressants. Its action involves blocking specific receptors (alpha2, 5-HT2, and 5-HT3) to increase the availability of both norepinephrine and serotonin simultaneously.

Q: Is it possible to be allergic to Zapex?

Yes, official documents state that Zapex is strictly contraindicated, meaning it must not be used, in patients who have a known hypersensitivity or allergy to mirtazapine or any of the other ingredients in the tablet.

Q: What is the expected timeline for a person to reach the full effect of Zapex?

Clinical experience described in official information suggests that the full therapeutic benefit of Zapex may take between four to eight weeks to fully develop. This is the general timeline observed in clinical experience.

Q: Do studies suggest Zapex works better for certain groups of people?

The primary research evidence for Zapex focused on specific adult populations. Regulatory bodies state that while research was conducted in specific groups like older adults, the available pivotal data for approval only applies to the adult populations studied and is insufficient for use in groups like children or adolescents.

Q: Can Zapex cause changes in blood pressure?

Official safety information lists a risk of orthostatic hypotension as a potential effect. Orthostatic hypotension is a drop in blood pressure that can cause dizziness when a person stands up quickly, especially in certain patient populations.

Q: Why is Zapex sometimes used in combination with other medicines?

The official label discusses the safety implications of co-administering Zapex with other medicines, particularly those that increase serotonin levels. This is addressed by noting the need to manage the increased risk of certain side effects, such as serotonin syndrome.

Q: What kind of monitoring is typically done when taking Zapex?

Because of the rare but serious risk of Agranulocytosis (a severe drop in white blood cells), patients are advised to seek medical attention immediately if they develop signs of infection like fever, chills, or a sore throat. In such cases, monitoring of the white blood cell count may be necessary.

Q: Does Zapex have a risk of causing confusion or memory issues?

Confusion is listed as a Common side effect in the official safety profile. Additionally, regulatory updates have noted reports of amnesia (memory loss) as an adverse reaction, and reports indicate that these effects often resolve after the medicine is discontinued.

Q: Does Zapex have any known interactions with herbal supplements like St. John's Wort?

Official documentation specifically advises caution when Zapex is used concurrently with the herbal supplement St. John's Wort. This is due to the potential for increased serotonergic effects and the subsequent risk of a serious condition called serotonin syndrome.

Q: How is Zapex eliminated from the body?

According to the pharmacokinetics section of the official label, Zapex is extensively broken down (metabolized) primarily in the liver. The drug and its byproducts are then eliminated from the body predominantly via the urine (about 75%) and, to a lesser extent, the feces (about 15%).

Q: Is it necessary to have routine blood tests while on Zapex?

The official label does not mandate routine blood tests for all patients. However, due to the risk of a rare blood disorder called Agranulocytosis, monitoring of the white blood cell count may be necessary if a patient develops signs of infection, such as fever or sore throat.

Q: Does Zapex have a risk of affecting blood sugar levels?

While the regulatory label mentions metabolic effects like weight gain, certain authoritative sources mention that Zapex may influence blood sugar control, particularly in patients who have diabetes.

Q: Is Zapex a brand name, and what is the chemical name?

Zapex is the specific brand name for the active ingredient Mirtazapine. The official chemical name is a complex structure: 5-methyl-2,5,19-triazatetracyclo[13.4.0.0^2,7.0^8,13]nonadeca-1(15),8,10,12,16,18-hexaene.

How should Zapex be stored and disposed of?

Storage Conditions for Zapex (Mirtazapine)

Zapex tablets must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), with regulatory permission for excursions up to 30 C (86 F). The product must be kept in its original container, which should be tightly closed and protected from both light and moisture.

For the orally disintegrating tablet (ODT) form, the tablet must remain in its blister pack until immediate use; it cannot be stored after removal. Handling of the ODT should be done with dry hands to prevent damage to the dosage form. All Zapex medication must be stored out of the sight and reach of children.

Disposal Requirements

Unused or expired Zapex should not be disposed of via wastewater or placed in standard household trash. Official regulatory guidance recommends utilizing a drug take-back program or consulting a pharmacist for disposal instructions. If a take-back program is unavailable, the FDA advises mixing the drug with an undesirable substance, sealing the mixture in a container, and discarding it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zapex found in:

A-Z Index: